NovaResp Technologies Inc.

NovaResp Technologies is a medical technology company that is developing the world’s first AI-enabled predictive and preventative continuous positive airway pressure (CPAP) machine. CPAP therapy is used to treat respiratory conditions such as obstructive sleep apnea, but more than 50 percent of patients don’t use their machines due to factors such as lack of comfort, unattractiveness, lack of portability, too much or too little air pressure, and noise. NovaResp’s proprietary continuous management of airway pressure (cMAP) software can be integrated into any existing CPAP machine, and uses low-pressure therapy which requires less energy, allowing the venture to develop its own CPAP machine that can be battery-enabled, wearable, in addition to being more comfortable and portable than current solutions.